Solve All Your Cancer Concerns with

Nano CASTTM

Stop Fear with Superior Understanding

Nano CASTTM  is an advanced and innovative technology designed for the detection of circulating tumor cells (CTCs) in the bloodstream. Circulating tumor cells are malignant cells that detach from primary or metastatic tumors and enter the circulatory system, where they contribute significantly to cancer progression, metastasis, and recurrence. The early identification of these cells is essential for informed clinical decision-making, timely risk assessment, preventive strategy development, and the optimization of therapeutic interventions.

Using advanced semiconductor technology, Nano CASTTM can accurately capture and count CTCs even in very low amounts in the bloodstream, providing you and your physician with valuable insights.

Screening

Assess your cancer risk before symptoms appear

Follow-up

Closely monitor treatment response

Monitoring

Detect disease recurrence faster than ever

What Are Circulating Tumor Cells (CTCs)?

CTCs (Circulating Tumor Cells) are cancer cells that have directly detached from a tumor and circulate in the bloodstream, acting like “seeds” ready to grow and spread to other organs.
In contrast, ctDNA (circulating tumor DNA) consists of fragments of DNA from dead cancer cells. Detecting CTCs provides more complete and meaningful information for treatment planning than ctDNA alone.

Characteristics Nano CASTTM (CTCs Testing) ctDNA Testing
Target Detected Whole cancer cells Fragments of cancer cell DNA
Information Obtained
Insights:
  • Quantity
  • Morphology
  • Characteristics
Quantitative data:
Indicates only the presence or absence of cancer traces.
Detection Sensitivity Faster detection is achieved through the integration of Semiconductor
with Microfluidics enhancing the efficiency of cancer cell capture. 		In the early stage, the quantity may be very low, making detection difficult.
Medical benefits
Covers all stages:
  • Risk screening
  • Follow-up monitoring
  • Surveillance for recurrence
 Primarily focused on monitoring treatment progress.
"CTCs testing is like 'capturing the criminal in person,' whereas ctDNA testing is only like 'finding the evidence the criminal left behind.'"
Nano CAST™

incorporates highly specific antibodies for the screening of 9 cancer types, in addition to a dedicated panel of antibodies designed for disease
monitoring and longitudinal follow-up.**

**Used for monitoring patients who have been diagnosed with a tumor or cancer.

Nano CASTTM

suitable for?

  • Individuals seeking cancer risk screening, particularly at an early stage before the onset of symptoms.
  • Individuals with a family history of cancer.
  • Individuals with high-risk lifestyles or behavioral factors.
  • Cancer patients, to support physicians in treatment planning and therapeutic response evaluation.
  • Cancer survivors who require ongoing monitoring for recurrence surveillance.

Move beyond uncertainty toward a future you can trust.

Consult a specialist today about Nano CASTTM

Click here